1. Bard Y (1974) Nonlinear parameter estimation. Academic Press, New York, p 176
2. Cano JP, Aubert C, Rigault JP, Gilli R, Coassolo PH, Monjanel S, Seitz JF, Carcassone Y (1981) Advantages and limitations of pharmacokinetics studies in the rationalization of anticancer therapy: methotrexate and 5-FU, Cancer Treat Rep 65 [Suppl 3]:33
3. Chabner BA (1982) Pyrimidine antagonists: In: Chabner BA (ed) Pharmacologic principles of cancer treatment. W. B. Saunders, Philadelphia, p 183
4. Collins JM, Dedrick RL, King FG, Speyer JL, Myers CE (1980) Nonlinear pharmacokinetics models for 5-fluorouracil in man: intravenous and intraperitoneal routes. Clin Pharmacol Ther 28:235
5. Diasio RB, Harris BE (1989) Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet 16:215